Experimental study demonstrates high efficiency and stability in mesoporous silica-anchored Cs2ZnCl4 quantum dots, highlighting a viable path for non-toxic optoelectronic applications.
All‐inorganic lead‐free Cs 2 ZnCl 4 perovskite quantum dots (QDs) attract significant attention due to their non‐toxicity and unique optoelectronic properties. However, the yield of Cs 2 ZnCl 4 colloidal QDs synthesized via ligand‐assisted reprecipitation (LARP) remains extremely low, and their stability is poor, limiting their applications. Here, we report a post‐processing strategy that employs mesoporous nano‐SiO 2 to anchor Cs 2 ZnCl 4 QDs within its pores, creating spatial confinement that prevents Cs 2 ZnCl 4 QDs aggregation and quenching while passivating surface defects and reducing non‐radiative recombination pathways. This strategy enables the powderization of Cs 2 ZnCl 4 colloidal QDs, and the Cs 2 ZnCl 4 /SiO 2 nano‐composite particles (NCP) exhibit bright blue photoluminescence (CIE 0.15, 0.12). Compared to the Cs 2 ZnCl 4 colloidal QDs, the Cs 2 ZnCl 4 /SiO 2 NCP demonstrates a 10 times increase in PL intensity, with a high PLQY (74.28%) and an ultrafast photoluminescence lifetime (2.4 ns). Moreover, due to nano‐SiO 2 protection, the Cs 2 ZnCl 4 /SiO 2 NCP exhibits excellent ambient conditions (>6 months, 86.6%) and harsh conditions (temperature, humidity, light, etc.) stability, which is superior to that of other reported halide perovskite QDs. This strategy offers a viable approach to address the challenges of low yield, low photoluminescence efficiency, and poor stability in colloidal perovskite QDs, thereby creating opportunities for their commercial application.
No takes yet. Share an insight, caveat, or question.
Chao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: